Goldfinch Biopharma is based in Cambridge. It has raised $160M in total funding. Latest round: Series B.
Goldfinch Biopharma is based in Cambridge. Goldfinch Biopharma has raised $160M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2020. The round record for Goldfinch Biopharma runs through 2020; nothing later has been disclosed. Investors on record include Third Rock Ventures, Gilead Sciences, Eventide Asset Management, Wellington Management Company, Ally Bridge Group, Casdin Capital and 4 others. 10 distinct backers are named across the disclosed rounds.
Goldfinch Biopharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026